Cargando…
BRD4 inhibition for the treatment of pathological organ fibrosis
Fibrosis is defined as excess deposition of extracellular matrix, resulting in tissue scarring and organ dysfunction. It is estimated that 45% of deaths in the developed world are due to fibrosis-induced organ failure. Despite the well-accepted role of fibrosis in the pathogenesis of numerous diseas...
Autores principales: | Stratton, Matthew S., Haldar, Saptarsi M., McKinsey, Timothy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497817/ https://www.ncbi.nlm.nih.gov/pubmed/28721198 http://dx.doi.org/10.12688/f1000research.11339.1 |
Ejemplares similares
-
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
por: Robinson, Emma L., et al.
Publicado: (2022) -
Epigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation
por: Felisbino, Marina B., et al.
Publicado: (2018) -
Putting the Heat on Cardiac Fibrosis: Hsp20 Regulates Myocyte-To-Fibroblast Crosstalk
por: Major, Jennifer L., et al.
Publicado: (2019) -
Treatment and Prevention of Histoplasmosis in Adults Living with HIV
por: McKinsey, David S.
Publicado: (2021) -
Therapeutic targets for cardiac fibrosis: from old school to next-gen
por: Travers, Joshua G., et al.
Publicado: (2022)